Celldex Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Celldex Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Celldex Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 2.06K %, a 12.2% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 2.06K +224 +12.2% Jun 30, 2024
Q1 2024 1.76K +126 +7.7% Mar 31, 2024
Q4 2023 1.37K -405 -22.8% Dec 31, 2023
Q3 2023 1.45K -499 -25.7% Sep 30, 2023
Q2 2023 1.83K -287 -13.5% Jun 30, 2023
Q1 2023 1.64K -700 -30% Mar 31, 2023
Q4 2022 1.78K -132 -6.9% Dec 31, 2022
Q3 2022 1.95K +319 +19.6% Sep 30, 2022
Q2 2022 2.12K +826 +63.8% Jun 30, 2022
Q1 2022 2.34K +877 +60.1% Mar 31, 2022
Q4 2021 1.91K +527 +38.1% Dec 31, 2021
Q3 2021 1.63K +455 +38.8% Sep 30, 2021
Q2 2021 1.3K +398 +44.3% Jun 30, 2021
Q1 2021 1.46K +846 +138% Mar 31, 2021
Q4 2020 1.38K +712 +106% Dec 31, 2020
Q3 2020 1.17K +448 +61.9% Sep 30, 2020
Q2 2020 898 +174 +24% Jun 30, 2020
Q1 2020 614 -68.8 -10.1% Mar 31, 2020
Q4 2019 670 +41.8 +6.65% Dec 31, 2019
Q3 2019 724 +152 +26.5% Sep 30, 2019
Q2 2019 724 +162 +28.7% Jun 30, 2019
Q1 2019 682 +129 +23.4% Mar 31, 2019
Q4 2018 628 +51.3 +8.89% Dec 31, 2018
Q3 2018 572 -11 -1.89% Sep 30, 2018
Q2 2018 562 -112 -16.6% Jun 30, 2018
Q1 2018 553 -248 -30.9% Mar 31, 2018
Q4 2017 577 -326 -36.1% Dec 31, 2017
Q3 2017 583 -472 -44.7% Sep 30, 2017
Q2 2017 674 -429 -38.9% Jun 30, 2017
Q1 2017 800 -337 -29.7% Mar 31, 2017
Q4 2016 903 -383 -29.8% Dec 31, 2016
Q3 2016 1.06K -213 -16.8% Sep 30, 2016
Q2 2016 1.1K -109 -8.99% Jun 30, 2016
Q1 2016 1.14K -54.3 -4.56% Mar 31, 2016
Q4 2015 1.29K +172 +15.4% Dec 31, 2015
Q3 2015 1.27K -22 -1.71% Sep 30, 2015
Q2 2015 1.21K -43.8 -3.48% Jun 30, 2015
Q1 2015 1.19K -78 -6.14% Mar 31, 2015
Q4 2014 1.11K -42.2 -3.65% Dec 31, 2014
Q3 2014 1.29K +425 +49% Sep 30, 2014
Q2 2014 1.26K +463 +58.3% Jun 30, 2014
Q1 2014 1.27K +597 +88.8% Mar 31, 2014
Q4 2013 1.16K +572 +97.9% Dec 31, 2013
Q3 2013 867 +302 +53.4% Sep 30, 2013
Q2 2013 793 +208 +35.6% Jun 30, 2013
Q1 2013 673 +76.2 +12.8% Mar 31, 2013
Q4 2012 584 Dec 31, 2012
Q3 2012 565 Sep 30, 2012
Q2 2012 585 Jun 30, 2012
Q1 2012 597 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.